Is mirtazapine (an antidepressant) considered an antipsychotic medication?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Mirtazapine an Antipsychotic?

No, mirtazapine is not an antipsychotic medication but rather a noradrenergic and specific serotonergic antidepressant (NaSSA) primarily used for the treatment of depression.

Classification and Mechanism of Action

Mirtazapine belongs to a distinct class of antidepressants with the following characteristics:

  • It is classified as a noradrenergic and specific serotonergic antidepressant (NaSSA) 1
  • It works by blocking presynaptic alpha-2 adrenergic receptors and postsynaptic serotonin type 2 and type 3 receptors 2
  • Its antidepressant effect appears related to dual enhancement of central noradrenergic and serotonin 5-HT1 receptor-mediated serotonergic neurotransmission 3

Primary Indications

Mirtazapine is primarily indicated for:

  • Treatment of major depression 1, 2
  • Particularly effective in patients with depression and comorbid insomnia or anorexia 4

Differentiation from Antipsychotics

Guidelines clearly distinguish mirtazapine from antipsychotic medications:

  1. In the NCCN Palliative Care guidelines, mirtazapine is specifically categorized as a "sedating antidepressant" separate from antipsychotic medications:

    • "For refractory insomnia, pharmacologic management includes the short-acting benzodiazepine lorazepam, the nonbenzodiazepine zolpidem, antipsychotic medications such as chlorpromazine, quetiapine, and olanzapine, and sedating antidepressants such as trazodone and mirtazapine." 4
  2. In clinical practice guidelines for pain management, mirtazapine is categorized as a neuromodulator, not an antipsychotic:

    • "Neuromodulators with the most proven efficacy in the treatment of chronic pain are low-dose tricyclic antidepressants, serotonin noradrenergic reuptake inhibitors, and mirtazapine." 4
  3. WHO guidelines specifically list antipsychotic medications separately from other psychiatric medications, with mirtazapine not included in the antipsychotic category 4

Medication Classification Tables

Medical guidelines consistently classify mirtazapine as an antidepressant, not an antipsychotic:

  • In a comprehensive table of medications associated with weight changes, mirtazapine is listed under "Antidepressants" rather than "Antipsychotics" 4

Potential Confusion

The confusion might arise because:

  1. Mirtazapine has been studied as an adjunctive treatment to antipsychotics in schizophrenia:

    • Research shows it may enhance the effect of first-generation antipsychotics when used in combination 5
    • However, this does not make mirtazapine itself an antipsychotic
  2. Mirtazapine has sedating properties that might be confused with the sedative effects of some antipsychotics:

    • It causes significant sedation, especially at lower doses (7.5-15mg) 6
    • This sedating effect is due to its H1 receptor antagonism, not antipsychotic properties 6

Clinical Applications Beyond Depression

While not an antipsychotic, mirtazapine has been studied for other psychiatric conditions:

  • Anxiety disorders (including PTSD, panic disorder, social anxiety disorder)
  • Obsessive-compulsive disorder
  • Somatoform disorders
  • As add-on therapy in schizophrenia (but not as a primary antipsychotic) 1, 7

In conclusion, mirtazapine is definitively classified as an antidepressant with sedating properties, not an antipsychotic medication, according to established clinical guidelines and pharmacological classification systems.

References

Research

Mirtazapine, an antidepressant.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Combination Therapy with Lamotrigine and Mirtazapine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Mirtazapine: other indications.

The Journal of clinical psychiatry, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.